What's new

Transfer of marketing authorisation: questions and answers

Transfer of marketing authorisation: questions and answers

Feb 18, 2025  0

Transfer of marketing authorisation: questions and answers

European medicines agencies network strategy (EMANS) to 2028 webinar, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 13 February 2025, 13:00 (CET) to 13 February 2025, 17:00 (CET)

European medicines agencies network strategy (EMANS) to...

Feb 18, 2025  0

European medicines agencies network strategy (EMANS) to 2028 webinar, Online, Eu...

European Medicines Agency post-authorisation procedural...

Feb 18, 2025  0

European Medicines Agency post-authorisation procedural advice for users of the ...

European Medicines Agency post-authorisation procedural...

Feb 18, 2025  0

European Medicines Agency post-authorisation procedural advice for users of the ...

Agenda of the CAT meeting 19-21 February 2025

Feb 18, 2025  0

Agenda of the CAT meeting 19-21 February 2025

Quick guide: How to search, view and download a Clinica...

Feb 18, 2025  0

Quick guide: How to search, view and download a Clinical Trial and a Clinical Tr...

Quick guide - Introduction: CTIS for SMEs and Academia ...

Feb 18, 2025  0

Quick guide - Introduction: CTIS for SMEs and Academia - CTIS Training Programme...

FAQs: Introduction to the Clinical Trials Regulation (E...

Feb 18, 2025  0

FAQs: Introduction to the Clinical Trials Regulation (EU) No 536/2014 - CTIS Tra...

Referral: Finasteride- and dutasteride-containing medicinal products, finasteride,dutasteride Article 31 referrals Under evaluation, 18/02/2025

Referral: Finasteride- and dutasteride-containing medic...

Feb 18, 2025  0

Referral: Finasteride- and dutasteride-containing medicinal products, finasterid...

Human medicines European public assessment report (EPAR): Onureg, azacitidine, Date of authorisation: 17/06/2021, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 18, 2025  0

Human medicines European public assessment report (EPAR): Onureg, azacitidine, D...

Onureg : EPAR - Procedural steps taken and scientific i...

Feb 18, 2025  0

Onureg : EPAR - Procedural steps taken and scientific information after the auth...

European Medicines Agency’s data protection notice rega...

Feb 18, 2025  0

European Medicines Agency’s data protection notice regarding personal data proce...

Maximum residue limits (MRL)

Maximum residue limits (MRL)

Feb 18, 2025  0

Maximum residue limits (MRL)

EMEA-003155-PIP01-21-M01

EMEA-003155-PIP01-21-M01

Feb 18, 2025  0

EMEA-003155-PIP01-21-M01

EMA Open Door Day, European Medicines Agency, Amsterdam, the Netherlands, from 9 May 2025, 09:45 (CEST) to 9 May 2025, 16:00 (CEST)

EMA Open Door Day, European Medicines Agency, Amsterdam...

Feb 18, 2025  0

EMA Open Door Day, European Medicines Agency, Amsterdam, the Netherlands, from 9...

Human medicines European public assessment report (EPAR): Azacitidine Accord, azacitidine, Date of authorisation: 13/02/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 18, 2025  0

Human medicines European public assessment report (EPAR): Azacitidine Accord, az...

ACT EU workshop on ICH E6 R3 (principles and Annex 1) , Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 19 February 2025, 09:30 (CET) to 20 February 2025, 14:00 (CET)

ACT EU workshop on ICH E6 R3 (principles and Annex 1) ,...

Feb 18, 2025  0

ACT EU workshop on ICH E6 R3 (principles and Annex 1) , Online, European Medicin...

Programme - EMA's Open Door Day

Feb 18, 2025  0

Programme - EMA's Open Door Day

Agenda - ACT EU workshop on ICH E6 (R3)

Feb 18, 2025  0

Agenda - ACT EU workshop on ICH E6 (R3)

Template for assessment report for the development of European Union herbal monographs and list entries

Template for assessment report for the development of E...

Feb 17, 2025  0

Template for assessment report for the development of European Union herbal mono...

Template for a European Union herbal monograph

Template for a European Union herbal monograph

Feb 17, 2025  0

Template for a European Union herbal monograph

Agenda of the COMP meeting 18-19 February 2025

Feb 17, 2025  0

Agenda of the COMP meeting 18-19 February 2025

Interested Parties to the HMPC

Interested Parties to the HMPC

Feb 17, 2025  0

Interested Parties to the HMPC

Human medicines European public assessment report (EPAR): Cibinqo, abrocitinib, Date of authorisation: 09/12/2021, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 17, 2025  0

Human medicines European public assessment report (EPAR): Cibinqo, abrocitinib, ...

Popular Posts

Contact lenses used to slow nearsightedness in youth have a lasting effect

Contact lenses used to slow nearsightedness in you...

Feb 9, 2025  0

China launches pricing reform for grid-connected renewable power

China launches pricing reform for grid-connected r...

Feb 10, 2025  0

Guest commentary: Every step counts to drive down greenhouse gas emissions with green materials

Guest commentary: Every step counts to drive down ...

Feb 9, 2025  0

New Siemens Software Automatically Identifies Vulnerable Production Assets

New Siemens Software Automatically Identifies Vuln...

Feb 9, 2025  0

Utilizing 3D and AR Technology to Visualize ADU Designs Pre-Construction

Utilizing 3D and AR Technology to Visualize ADU De...

Feb 9, 2025  0

Recommended Posts

Fortune Patrol Monopoly Go: Everything You Need to Know

Fortune Patrol Monopoly Go: Everything You Need to...

Feb 13, 2025  0

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.